Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broad Chest Aerosol in Coronary Microvascular Dysfunction
ChiCTR2500100146Phase 4Not yet recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Apr 2025
- Countries
- 1
01
Overview
Phase 4, open-label trial of broad chest aerosol in Coronary Small Vessel Disease (CMD) (3 arms), sponsored by Xuzhou Central Hospital. Primary endpoints: QFR and IMRangio, TID ratio and 2 more. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
broad chest aerosol
03
Conditions
Coronary Small Vessel Disease (CMD)
Beyond the preview
Go deeper on ChiCTR2500100146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100146.